Bucci E, Razynska A, Kwansa H, Matheson-Urbaitis B, O'Hearne M, Ulatowski J A, Koehler R C
Department of Biochemistry, University of Maryland Medical School, Baltimore 21201, USA.
J Lab Clin Med. 1996 Aug;128(2):146-53. doi: 10.1016/s0022-2143(96)90006-2.
Research on red cell substitutes requires the availability of oxygen-carrying fluids for physiologic experiments. This article describes the procedure for in-house production of such a fluid. It contains a hemoglobin-based oxygen carrier obtained by reacting human hemoglobin with bis-(3,5-dibromosalicyl) sebacate. This reagent produces intramolecular cross-links between the beta 82 lysines and between the alpha 99 lysines, respectively. The oxygen half-saturation pressure (P50) of the fluid is near 34 mm Hg at 37 degrees C, with a Hill's parameter of n = 2.2. The half-time of intravascular retention is near 3.0 hours in the rat and 6.5 hours in the cat. Spectrophotometric analyses of arterial and venous plasma from an infused rat reveal an efficient oxygen delivery to the tissues by the oxygen carrier. Therefore, this new cross-linked human hemoglobin can be produced in quantities sufficient for in vivo evaluation and with an oxygen affinity and cooperativity adequate for oxygen unloading in plasma.
红细胞替代物的研究需要有用于生理学实验的携氧液体。本文描述了一种此类液体的内部生产程序。它包含一种基于血红蛋白的氧载体,该氧载体通过将人血红蛋白与双-(3,5-二溴水杨酸)癸二酸酯反应获得。该试剂分别在β82赖氨酸之间和α99赖氨酸之间产生分子内交联。该液体在37℃时的氧半饱和压力(P50)接近34mmHg,希尔系数n = 2.2。在大鼠体内血管内保留的半衰期接近3.0小时,在猫体内为6.5小时。对输注大鼠的动脉和静脉血浆进行分光光度分析表明,该氧载体能有效地将氧气输送到组织。因此,这种新的交联人血红蛋白能够大量生产,足以用于体内评估,并且具有适合在血浆中卸载氧气的氧亲和力和协同性。